Literature DB >> 860890

Hyperserotonemia and amine metabolites in autistic and retarded children.

H G Hanley, S M Stahl, D X Freedman.   

Abstract

Mean whole blood serotonin (5-HT) levels were elevated in groups of autistic and severely retarded children. Eight of 27 (30%) individual autistic children, 13 of 25 (52%) severely retarded children, two of 23 (9%) mildly retarded children, and none of the control children had statistically significant blood 5-HT levels elevations (hyperserotonemia). Hyperserotonemic autistic children excreted more urinary 5-HT, 5-hydroxyindoleacetic acid (5-HIAA), tryptamine, and vanillylmandelic acid than did mildly retarded children with normal blood 5-HT levels. Rates of depletion and repletion of blood 5-HT levels in these two groups following reserpine therapy were identical. Oral tryptophan administration doubled urinary 5-HIAA excretion in both groups and raised urinary 5-HT levels in hyperserotonemic autistic children, but lowered urinary 5-HT in mildly retarded, normal blood 5-HT children. No clear mechanism for hyperserotonemia was found; the rationale for further investigations is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 860890     DOI: 10.1001/archpsyc.1977.01770170031002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  51 in total

Review 1.  Maternal SSRIs experience and risk of ASD in offspring: a review.

Authors:  Zainab Fatima; Aqeela Zahra; Maria Ghouse; Xu Wang; Zonghui Yuan
Journal:  Toxicol Res (Camb)       Date:  2018-07-11       Impact factor: 3.524

Review 2.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

3.  Platelet serotonin, a possible marker for familial autism.

Authors:  J Piven; G C Tsai; E Nehme; J T Coyle; G A Chase; S E Folstein
Journal:  J Autism Dev Disord       Date:  1991-03

Review 4.  Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies.

Authors:  Yusuf Cem Kaplan; Elif Keskin-Arslan; Selin Acar; Kaan Sozmen
Journal:  Br J Clin Pharmacol       Date:  2017-08-27       Impact factor: 4.335

Review 5.  Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.

Authors:  Noha F Minshawi; Sarah Hurwitz; Danielle Morriss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2015-06

Review 6.  Integrins in synapse regulation.

Authors:  Yun Kyung Park; Yukiko Goda
Journal:  Nat Rev Neurosci       Date:  2016-11-04       Impact factor: 34.870

7.  Nanostructure-initiator mass spectrometry (NIMS) imaging of brain cholesterol metabolites in Smith-Lemli-Opitz syndrome.

Authors:  G J Patti; L P Shriver; C A Wassif; H K Woo; W Uritboonthai; J Apon; M Manchester; F D Porter; G Siuzdak
Journal:  Neuroscience       Date:  2010-07-27       Impact factor: 3.590

8.  Differential negative air ion effects on learning disabled and normal-achieving children.

Authors:  L L Morton; J R Kershner
Journal:  Int J Biometeorol       Date:  1990-05       Impact factor: 3.787

9.  Whole blood serotonin and tryptophan in autism: temporal stability and the effects of medication.

Authors:  R B Minderaa; G M Anderson; F R Volkmar; D Harcherick; G W Akkerhuis; D J Cohen
Journal:  J Autism Dev Disord       Date:  1989-03

Review 10.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.